Recipharm cutting jobs in Sweden; Almac expands its manufacturing tech;

> Recipharm is planning to cut about 100 jobs in its native Stockholm, looking to reduce costs. More

> A New York private equity outfit acquired a 90% stake in Italian contract drugmaker Doppel Farmaceutici. Story

> Almac has expanded its drug development services to include new processing and encapsulation technology at its U.K. hub. Item

Suggested Articles

Symphony Health has inked a new deal with Close-Up International aimed at boosting its global data services.

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.